Have multiple conditions? Click here
You are viewing Clinical Trials In Kentucky
Have multiple conditions? Click here

Showing 1-100 of 751
There are 751 trials in Kentucky
Name City State Zip
Trial of STAHIST in Seasonal Allergic Rhinitis Somerset KY 42501
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Somerset KY 42503
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) Salem KY 42078
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus Paducah KY 42003
A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease Paducah KY 42003
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl Paducah KY 42003
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate Paducah KY 42003
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma Paducah KY 42001
An Open-Label Study of Trastuzumab-MCC-DM1 (T-DM1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Paducah KY 42001
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists Paducah KY 42001
A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer Paducah KY 42001
A Study Evaluating the Efficacy and Safety of GDC-0449 in Operable Basal Cell Carcinoma (BCC) Paducah KY 42001
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis Paducah KY 42001
XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis. Paducah KY 42003
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease Paducah KY
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure Paducah KY 42003
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer Paducah KY 42003
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease Paducah KY
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients. Paducah KY
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Owensboro KY 42303
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Owensboro KY 42303
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Owensboro KY 42303
Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging Owensboro KY 42303
Assessment of Growth of Infants Fed a New Formula Owensboro KY 42301
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma Owensboro KY 42301
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder Owensboro KY 42301
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants Owensboro KY 42303
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers Owensboro KY 42303
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Owensboro KY 42303
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy Owensboro KY 42303
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study Owensboro KY
Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement Owensboro KY 42303
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Owensboro KY 42303
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study" Mt. Sterling KY 40353
Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer Mt. Sterling KY 40353
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC) Mt. Sterling KY 40353
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) Mt. Sterling KY 40353
Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer Mt. Sterling KY 40353
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy Mt. Sterling KY 40353
Diabetic Peripheral Neuropathic Pain (DPNP) Madisonville KY 42431
Crossover Post-herpetic Neuralgia (PHN) Madisonville KY 42431
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) Madisonville KY 42431
Efficacy and Safety Evaluation of SAR236553 (REGN727) in Patients With Primary Hypercholesterolemia and LDL-cholesterol on Stable Atorvastatin Therapy Madisonville KY 42431
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Madisonville KY 42431
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients. Madisonville KY
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) Madisonville KY 42431
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension Madisonville KY 42431
Paclitaxel in Treating Patients With Ovarian Stromal Cancer Louisville KY 40202
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Louisville KY 40202
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Louisville KY 40202
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Louisville KY 40202
Collecting Tumor Samples From Patients With Gynecological Tumors Louisville KY 40202
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Louisville KY 40202
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Louisville KY 40202
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Louisville KY 40202
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Louisville KY 40202
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Louisville KY 40202
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Louisville KY 40202
Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma Louisville KY 40202
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma Louisville KY 40232
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Louisville KY 40232
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Louisville KY 40232
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Louisville KY 40232
Study of Late-Occurring Complications in Childhood Cancer Survivors Louisville KY 40232
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Louisville KY 40232
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Louisville KY 40232
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor Louisville KY 40232
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Louisville KY 40232
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Louisville KY 40232
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Louisville KY 40232
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Louisville KY 40232
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Louisville KY 40232
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Louisville KY 40232
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes Louisville KY 40232
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Louisville KY 40232
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Louisville KY 40232
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Louisville KY 40232
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission Louisville KY 40232
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Louisville KY 40232
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Louisville KY 40232
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Louisville KY 40232
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight Louisville KY 40232
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Louisville KY 40232
Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET) Louisville KY 40232
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants Louisville KY 40232
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Louisville KY 40232
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Louisville KY 40232
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Louisville KY 40232
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial Louisville KY 40232
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Louisville KY 40232
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Louisville KY 40232
Study of Kidney Tumors in Young Patients Louisville KY 40232
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Louisville KY 40232
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Louisville KY 40232
Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma Louisville KY 40232
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Louisville KY 40232
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Louisville KY 40232
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Louisville KY 40232
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Louisville KY 40232
Stem Cell Related Donor Safety Study Louisville KY 40232
View Clinical Trial Facilities in Kentucky

Showing 1-100 of 751
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register